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Abstract
Routine sperm parameters are used to evaluate fertility potential of the male partner. Since 
the introduction of intracytoplasmic sperm injection (ICSI), it seems that the importance 
of routine parameters of sperm morphology has decreased in the field of assisted repro-
duction. ICSI has facilitated to achieve fertilization, embryo development, and pregnan-
cies, from the treatment of males with poor-quality spermatozoa. Morphology is the only 
criteria for sperm aspiration during ICSI. Routine criteria are based on the raw ejaculate-
stained sperm cells. Thus, it is important to score and aspirate a good-quality motile sper-
matozoon, which will contribute to the quality of the developing embryo after ICSI, in 
real time of the procedure. In ICSI, assessment of sperm morphology is limited due to the 
low magnification (200 × 400×) and concomitant low resolution. By using intracytoplasmic 
morphologically selected sperm injection (IMSI), it was demonstrated that a spermatozoon 
with normal morphology, and more precisely normal nucleus, might affect the incidence 
of pregnancy. Although the usage of IMSI is currently wider, it is necessary to standardize 
which sperm to aspirate, due to criteria based on accumulating data. Correlation to DNA 
integrity, embryo development in vitro, female age, male age, or the routine use of IMSI for 
all cases are raised in order to maximize the efficiency of IMSI technology.
Keywords: IMSI, high magnification, sperm morphology, ICSI, embryo quality,  
sperm quality, real time sperm selection, IVF
1. Introduction
Following dedicated research and treatment of Patrick Steptoe and Robert G Edward in 
Bourn Hall, Cambridge, the first in vitro fertilization (IVF) baby girl Louise Brown was born 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
in 1978. This revolutionary assisted reproductive technology (ART) attempt brought the ful-
fillment of a vision to hundreds of thousands of infertile couples to conceive and deliver. 
The main idea behind the development of the technique was treating women with mechani-
cal factor infertility. Despite the great success of IVF, poor results were obtained in cases of 
severe male infertility. IVF outcome was satisfactory when oocytes were inseminated with 
>1.5 million spermatozoa and at least 50% motility could be observed in the specimen. This 
major limitation of sperm insemination in routine IVF was overcome by intracytoplasmic 
sperm injection (ICSI), introduced by Palermo in 1992 [1]. The injection of a single sperm 
into an oocyte, which revealed fertilization and development of viable in vitro embryos, 
gave a rapid solution to men with severe forms of male factor infertility, allowed application 
to other forms of infertility. Nowadays, it serves as the main tool for assisting couples to 
fulfill their wish to conceive [2]. Furthermore, it is also used for various infertility indications 
as low number and poor morphology of oocytes, thick zona pellucida, pre-implantation 
genetic diagnosis or screening (PGD, PGS), cases of hepatitis C and human immunodefi-
ciency virus, in vitro maturation, and oocyte cryopreservation. The usage of ICSI enabled 
to achieve fertilization, embryo development, pregnancies, and deliveries. It has been 
reported that strict morphologic criteria do not affect ICSI outcomes [3–9]. On the other 
hand, scientists indicated that the paternal gamete influences the resulting embryo, mainly 
at the level of blastocyst formation. Several points of negative paternal impact, both genetic 
and epigenetic, have been identified in embryos following the injection of poor-quality 
spermatozoa into the oocyte. Using ICSI also clarified some points of the paternal influ-
ence on the embryo development, mainly in vitro [10–20]. The specific injected sperm might 
affect the health of the newborns [21]. Several years ago, a series of reports pointed out that 
children born as a result of ART were found to have increased frequencies of a number of 
diseases known to have an epigenetic etiology [22–26], mainly after ICSI [27, 28]. Recently, 
Santos et al. evaluated the genome-wide DNA methylation together with chromatin organi-
zation in human embryos derived by either IVF or ICSI. In this report it was found that infer-
tility per se, rather than ART procedures, may play an important part in predisposition to 
epimutations that leads to diseases of an epigenetic basis. Interestingly, embryos developing 
to the blastocyst stage had an apparently normal epigenotype irrespective of the procedure 
used. These investigators concluded that ICSI per se does not lead to an increased inci-
dence of epigenetic errors [29]. It is accepted that routine morphology characteristics may 
not necessarily describe the quality of the specific single spermatozoon that was injected 
into the oocyte. Semen analyses, which describe the general picture of sperm quality of the 
raw ejaculate, are based on the examination of fixed and stained sperm cells. The latest, 
obviously, is not suitable for treatment any more. Aspiration of a specific sperm cell, and its 
injection into the oocyte, during ICSI, regularly takes place under the magnification of 200× 
or 400×. The sperm cell is randomly chosen when spermatozoa with major morphological 
abnormalities are generally omitted due to the experienced eyes of the embryologist. It is 
questionable as to what tool should be used to evaluate morphological criteria in real time 
during ICSI, which will enable to select a specific spermatozoon, with the highest predictive 
value for better fertilization, embryo developmental, implantation and pregnancy. De Vos 
et al. showed a correlation between the gross morphology of the individual injected sperm 
cell and the formation and development of the resultant embryo. These scientists admitted 
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that the low magnification (e.g. magnification of 400× during ICSI) and concomitant low 
resolution of the morphology of the motile sperm cell have been the limiting factors of their 
study [30]. It was demonstrated that using a high-power inverted light microscope with a 
zoom ≥6000× for the examination of motile spermatozoa in real time might positively affect 
the outcome of ICSI, in terms of fertilization rate, embryo development, and the occurrence 
of pregnancies [31–35].
2. Intracytoplasmic morphologically selected sperm injection step by 
step
2.1. The principle of the IMSI microscope
The term IMSI was defined by Bartoov et al. [32, 33]. The idea was based on the magnifica-
tion up to 6000× and more of the motile sperm cell in real time [33, 35–38]. The sperm analy-
sis is performed using an interference phase contrast inverted microscope with the optics of 
Nomarski. The magnified image of the sperm cell is displayed on a screen. The final magnifi-
cation of the “on-screen image” is actually a combination of the magnification of the objective, 
the camera adapter, ratio between the diagonal screen size in mm, diagonal of the camera 
chip size in mm, and internal magnification of the microscope. Depending upon these spe-
cific characteristics of an IMSI system, the final value of the magnification might vary from 
6000× to 6600× as described earlier. It should be clarified that the final various magnifications 
achieved in IMSI are actually a result of zoom on the image of the sperm cell, which magni-
fies the structures of its surface and cannot be observed in magnification of 200–400×, due to 
objective limitations of the human eyes.
2.2. Preparation of the IMSI dish
The high magnification of the objective (100×) with the optics of Nomarski requires a dish 
with a glass bottom. Droplets of the medium, approximately droplets from 1 to 4 μl, should 
be located on the dish as described in the diagram of an IMSI dish (Figure 1).
In Figure 1, the diagram of the IMSI dish describes the arrangement of the observation drop-
lets with spermatozoa, droplets with PVP, droplets of clean medium for the selected sperma-
tozoa, and clean droplets for the injection of the oocytes. The latest should be replaced with 
fresh droplets of media, prior to the ICSI procedure.
Observation droplets: three droplets of 2 μl are located in the left side of the dish. In these drop-
lets, 1 μl of the processed sperm cells of the sperm ejaculate will be inserted. These droplets 
of the sperm culture medium might contain, in correlation with the intensity of the sperm 
motility, between 0 and 10% polyvinylpyrrolidone (PVP) solution [34].
Clean droplets of a clean sperm culture medium: this is required to host the scored sperm cells 
after the evaluation. In each droplet, aspirated spermatozoa with a distinct morphological 
score are located.
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Clean droplet of PVP 10%: droplets of 1 μl are located in parallel to the droplets with the sper-
matozoa. When the intensity of the processed spermatozoa is not high, the authors like to 
create tiny “bridges” between these two droplets. The tiny bride will allow the passage of 
spermatozoa to the 10% PVP droplet and it eases the detection on the spermatozoa, as motil-
ity of the examined spermatozoa is slowed down. It is recommended to draw tiny extensions 
from the rim of the PVP droplets to capture the heads of the motile sperm cells. All droplets 
should be covered by mineral culture oil, which is generally used for the ICSI procedure.
The authors recommend that based on their existing design of the IMSI dish, each laboratory 
should adapt its special design for the arrangement of the droplets, in accordance with the 
preference of the laboratory where the ICSI procedure takes place.
3. IMSI in practice
The freshly ejaculated semen is centrifuged at approximately 360 ×g for 10 min. In cases when 
sperm concentration is <5 × 106, centrifugation is performed for 1520 min. The pellet is resus-
pended in 0.5 ml of sperm wash solution (Sperm Preparation Medium, Origio, Denmark). 
Further assessment is performed by using the bilayer density gradient: 0.5 ml of 50% gradient 
Figure 1. Diagram of an IMSI dish.
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solution and 0.5 ml of 80% (Supra Sperm Origio, Denmark) for 15 min. In severe oligospermic 
cases, 0.3 ml of each of the gradient layers is used and centrifugation in 300 × g should last up 
to 1 h [39, 40]. Final sperm pellet is resuspended in 50–100 μl. Approximately a droplet of 1 μl 
is placed inside the observation droplet of the pre-prepared IMSI dish. During the observation, 
motile spermatozoa with rough morphological abnormalities are omitted and not aspirated. 
Other motile sperm cells are aspirated and evaluated inside the ICSI pipette or in the clean 
PVP droplet and scored as mentioned above. The individual scored sperm cell is then placed 
into the appropriate droplet, in the IMSI dish [32, 35]. Aspiration of sperm cells is performed 
by the means of micromanipulations. There is no preference for a certain micromanipulation 
system. One should work with a system which is the easiest to handle, with his own hands.
3.1. Choosing the sperm
The group of Bartoov classified the selected spermatozoa morphology as “normal” and “second” 
choice, based on the data collected by scanning and transmission electron microscopy. Some 
characteristics of the morphology of the head of the sperm cell such as smoothness, symmetry, 
oval configuration, average length and width (4.75 ± 0.28 and 3.28 ± 0.20 mm, respectively), and 
nuclear chromatin mass containing no more than one vacuole were defined for normalcy of the 
sperm nucleus [32, 33]. The “second-choice” motile sperm was not clearly depicted. One might 
only speculate that during IMSI, when no normal head spermatozoa can be found, the alterna-
tive then is to select motile sperm cells that are morphologically the second-best choice.
The Cassuto and Barak Score was developed in order to define more precisely the preferable 
spermatozoon that should be injected into the oocyte, in real time [35]. This scoring system 
was established after checking and taking into consideration the sperm defects, which nega-
tively affect the development of the embryo in vitro and had the name of HAVBIC: Head: 
normalcy and shape, Acrosome: presence or absence, Vacuoles: presence or absence, Basis 
of the sperm head, Insertion: the axial position of the sperm, and Cytoplasmic droplet: pres-
ence or absence. Logistic regression was used for fertilization and embryo development as 
dependent variables. Coefficients were calculated and tested by comparing receiver operating 
characteristic (ROC) curves. The best results were achieved with an area under the curve of 
0.618, deriving the following formula: Score of spermatozoa = 2 × Head + 3 × Vacuole + 1 × 
Base. Following these findings, this classification system took into consideration three major 
parameters of the sperm nucleus: normalcy of shape and size of sperm head, lack of vacuoles 
and normalcy of the base of the head of the specific spermatozoon. Each of the normal param-
eter received a value = 1 when normal or = 0 when abnormal. Classification of the individual 
sperm cell, with a maximum of score 6, is calculated by the embryologist, who performs the 
IMSI, with this friendly formula, described above, and distinguishes between three classes:
Class 1: spermatozoa of highest quality, score 4–6; class 2: spermatozoa, score 1–3; class 3: 
low-quality spermatozoa, score 0. In their study a difference was noted between the fertiliza-
tion rate of oocytes with regard to the classification of the injected spermatozoa (P < 0.04; chi 
square = 6.31). A pair-wise comparison showed a higher fertilization rate in oocytes injected with 
class 1 spermatozoa in comparison to class 3 (P < 0.01; chi square = 6.3). A difference was noted 
in the development rate into expanded blastocyst (P < 0.03; chi square = 6.71), no expanded blas-
tocyst was observed in embryos resulted from injection of class 3 spermatozoa (score of 0) [35].
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4. IMSI in patients with a high rate of sperm DNA fragmentation
DNA integrity was assessed by Hazout et al. in 72 patients, referred to IMSI and ICSI. DNA 
fragmentation rate was evaluated by TUNEL assay. Improvement of clinical outcomes was 
evident both in patients with an elevated degree of sperm DNA fragmentation and in those 
with normal sperm DNA status [36]. Similar results were obtained by de Almeida Ferreira 
Braga et al. and Setti et al., who showed that fertilization and high-quality embryo rates were 
similar in patients with a high incidence of sperm DNA fragmentation tested in sibling oocytes 
split into ICSI and IMSI. Their observation suggested that IMSI, but not DNA sperm fragmen-
tation assay per se, could be a beneficial tool in improving IVF-ICSI results [41, 42]. In another 
independent study no correlation was found between abnormal sperm head morphology as 
assessed by high magnification (score 0) and DNA fragmentation. However, the rate of chro-
matin decondensation of their score 0 spermatozoa was twice as high as the spermatozoa that 
scored 4–6 (19.5% vs. 10.1%; P < 0.0001) [43]. This finding might explain the former observa-
tion of these researchers that no expanded blastocyst was developed following the injection of 
spermatozoa with the lowest morphology score [35].
5. IMSI and head-sperm vacuoles
Vanderzwalmen et al., classified the spermatozoa according to the presence and size of vacu-
oles into four groups: Grade I: normal shape and no vacuoles; Grade II: normal shape and 
maximum of two small vacuoles; Grade III: normal shape and more than two small vacu-
oles or one large vacuole; and Grade IV: large vacuoles in conjunction with abnormal head 
shapes or other abnormalities at the level of the base of the sperm head. The outcome of 
embryo development in a group of 25 patients after sibling oocyte injection with the four dif-
ferent grades of spermatozoa showed no significant difference in embryo quality up to day 3. 
However, the occurrence of blastocyst formation was 56.3 and 61.4% with grade I and II 
spermatozoa, respectively, compared with 5.1% with grade III and 0% with grade IV, respec-
tively (P < 0.001) [44]. It is not clear yet why presence of vacuoles in the sperm head is such 
an important parameter of sperm quality. Some reports showed no correlation between the 
appearances of vacuoles to male infertility [45–47]. One of these studies was an unpowered 
investigation [47] and another evaluated the sperm under magnification of 1000× [45]. Many 
others reported that vacuoles might negatively be associated with male fertility potential 
[32–37, 44, 48–54]. Moreover, investigation of the relation between sperm vacuoles and acro-
some reaction suggested that there might be a negative link between presence of vacuoles and 
acrosome reaction of the sperm [55, 56]. Consequently, IMSI could be a method for assisting 
the removal of the acrosome reaction-resistant spermatozoa.
The personal attitude of the authors of the current dissertation is that majority of abnormali-
ties observed under the high magnification of IMSI in real time are probably not visible while 
using routine conditions with lower magnifications. It is likely, though, that the benefit of scor-
ing scale of the sperm cell is a kind of “fine tuning”; IMSI therefore is more beneficial for motile 
spermatozoa which have normal morphological appearance under magnification 200–400×.
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6. IMSI should not be used for all
It seems that IMSI was a promising revolutionary technique in terms of improving the out-
come of ICSI treatments. One might agree that high magnification achieved by the technique 
contributes with a better evaluation of the aspirated sperm cell for the injection providing 
encouraging results. On the other hand, prolonged sperm manipulation, special instrumenta-
tion, additional number of embryologists who should be trained and expertly perform the 
technology, and the additional cost for the patients might increase the cost effectiveness of 
the procedure. Taking all the above into consideration, patients should be given counseling to 
undergo IMSI, for a better chance to conceive.
It appears that there is no advantage or benefit over standard ICSI in terms of clinical outcome 
in an unselected infertile population. Although there were trends for higher implantation, clin-
ical pregnancies, and live birth rates in the IMSI group, using the technique did not reveal an 
improvement in the clinical outcome compared with ICSI [57, 58]. The authors of the current 
publication, therefore, will try to discuss the benefits of IMSI in cases of patients with repeated 
implantation failures, severe male factor infertility, and advanced paternal and maternal age.
6.1. Patients with repeated implantation failures
Sixty-two couples with at least two previous consequent pregnancy failures after routine 
ICSI cycles underwent IMSI in the following cycle. The matched control group comprised 
50 couples, who underwent routine ICSI treatment and previously experienced the same 
number of ICSI failures in the same center. Fertilization and top-quality embryo rates were 
similar in both groups. A higher pregnancy rate with a lower miscarriage rate were achieved 
in the IMSI group, in comparison to the control group (66.0% vs. 30.0%; P < 0.01; 33.0% vs. 
9.0%; P < 0.01, respectively) [33]. Following that study, this new concept of sperm selection 
prior to ICSI was undertaken in additional centers, with encouraging results. Efficacy of 
IMSI was examined, for instance, in 12 couples with two or more repeated conventional 
ICSI failures, who underwent an additional conventional ICSI attempt, followed by a high 
magnification IMSI attempt. Fertilization and cleavage rates and embryo morphology were 
similar when we compared the two sequential attempts (ICSI attempt vs. the following IMSI 
cycle). However, improved clinical outcomes such as implantation, pregnancy, delivery, 
and birth rates were observed in IMSI attempts when compared with ICSI (20.3% vs. 0.8%, 
37.6% vs. 2.4%, 33.6% vs. 0.0%, 17.6% vs. 0.0%, respectively; P < 0.001) [36]. Another meta-
analysis compared the outcomes of conventional ICSI vs. IMSI cycles. It was concluded that 
IMSI not only improves the percentage of top-quality embryos, implantation, and preg-
nancy rates but also reduces miscarriage rates as compared with ICSI [59]. Findings of a 
retrospective study in 42 couples supported the former as well. These scientists examined 
the efficiency of the IMSI technique in patients with at least three repeated IVF-ICSI failure. 
The investigators demonstrated superior implantation, clinical pregnancy, and live birth 
rates in the IMSI group, moreover a lower miscarriage rate [60]. These data, in addition to 
the abovementioned, pointed toward IMSI as an important tool for the selection of the best 
spermatozoon for the injection of oocytes in cases of repeated IVF treatment failure.
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6.2. IMSI in cases of severe male factor infertility
Usage of IMSI had a significant contribution to the accumulated knowledge of male infertil-
ity. At present, few randomized controlled trials are available assessing the advantages of 
IMSI over the conventional ICSI procedure. Antinori et al. assessed 446 couples, randomly 
referred to ICSI or IMSI, with at least 2 previous diagnoses of male factors due to severe oli-
goasthenoteratozoospermia [53]. Despite their initial poor reproductive prognosis, patients 
with two or more previous failed attempts benefited the most from IMSI not only in terms of 
increased pregnancy rate (29.8% vs. 12.9%; P = 0.017) but also lower miscarriage rates. Patients 
diagnosed with poor reproductive prognosis with two or more previous failed attempts ben-
efited the most from IMSI. Study of patients with motile sperm less than 0.1 × 106/ml after the 
swim-up technique showed a positive influence of IMSI on fertilization, implantation, and 
pregnancy rates [42, 61]. More reports regarding patients with isolated teratozoospermia or 
severe oligospermia pointed to the benefits following the selection of injected sperm cell using 
IMSI. Higher clinical pregnancy and higher implantation rates were observed, in comparison 
to the conventional aspiration of spermatozoa in ICSI [62, 63].
7. IMSI: maternal age and pre-implantation genetic screening
Age-related decline in the quality of the oocytes, which affects the ICSI outcome, is a known 
phenomenon. Cassuto et al. distinguished between the quality of embryos resulting from 
oocytes of women younger than 30 years and those from women of 30 years and older, fol-
lowing the injection of spermatozoa selected using IMSI. When class 2 or 3 spermatozoa 
(moderate and bad morphological score) was injected, a lower rate of best and good embryos 
developed in the group of the older female patients (>30 years old) in comparison with the 
rate in the younger group (maternal age ≤ 30). Conversely, when a high-quality spermato-
zoon (score 4–6) was injected, the age-related quality of the oocyte is negligible; no difference 
was detected when the ratio of high-quality embryos was compared in young and older 
women. This is logical because these “top spermatozoa” do not need any repair. According 
to their findings, these researchers have pointed at the important contribution of a high-
quality spermatozoon, scored in a high magnification microscope, for the injection of oocytes 
aspirated from women of 30 years and older [35]. This outcome is not surprising because 
younger oocytes are capable of “repairing” the DNA of the injected spermatozoon. In ICSI, 
the direct sperm deposition probably does not have a delay in the cell cycle, as it might 
happen due to insemination in vitro of the oocytes. The extra time helps to save maternal 
ribonucleic acid (mRNA), which partially might overcome epigenetic defects [11, 16, 19, 64].
Embryo chromosomal status was examined in couples who underwent their first IVF-PGS 
cycle for aneuploidy due to advanced maternal age [65]. Couples were randomly addressed 
to routine ICSI or IMSI (n = 60). All cases of sperm concentration less than 1 × 106/ml and 
sperm motility less than 20% were excluded from the study to minimize the influence of male 
factor infertility.
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There was an increased incidence for sex chromosome aneuploidy in ICSI embryos when 
compared with IMSI (23.5% vs. 15.0%, respectively). IMSI was associated with a lower risk of 
sex chromosome abnormalities (odds ratio 0.57; confidence interval 0.37–0.90). The incidence 
of chaotic embryos was also higher with the ICSI procedure in comparison to IMSI (27.5% vs. 
18.8%). An unexpected difference in gender incidence rates of euploid embryos was detected. 
The latest was supported by Setti et al., when a higher incidence of XX embryos derived from 
IMSI cycles in comparison with ICSI was noticed (66.9% vs. 52.5%, respectively) [42]. It is 
possible that IMSI-selected “normal” spermatozoa may carry a higher proportion of the X 
chromosome, which might lead to such findings.
Data also demonstrated a consistent decline in semen quality, as reflected by morphological 
evaluation by high-power microscope magnification, with increased age, suggesting the use 
of IMSI as routine in the older group of patients [66, 67].
7.1. IMSI and paternal age
Regarding the question of sperm quality in correlation to male age, it was described that 
increased male age is associated with a decrease in semen volume of 3–22%, a decrease in 
sperm motility of 3–37%, and a decrease in percentage of normal sperm of 4–18%, when com-
paring 30-year-old men with 50-year-old men, with no consistent effect on sperm concentra-
tion. Moreover, with control for a female partner, a relative decrease in pregnancy rates of 23 
and 38%, increased risks for subfecundity ranging from 11 to 25%, and relative increase in 
months to achieve pregnancy up to 20% were found, comparing men <30 years old with men 
>50 years old, respectively [66]. Recently, IMSI provided remarkable information. Considering 
assessment of semen samples from 975 men who underwent IMSI, two forms of spermatozoa 
were considered: normal spermatozoa and spermatozoa with large nuclear vacuoles (LNV) 
[67]. At least 200 spermatozoa per sample were evaluated and the percentages of normal and 
LNV spermatozoa were determined. The subjects were divided into three groups accord-
ing to age: Group I ≤ 35 years old; Group II: 3640 years; and Group III ≥ 41 years. Ratio of 
normal sperm cells in the older group (Group III) was lower than in the younger groups (I 
and II; P < 0.05). Percentage of LNV spermatozoa was higher in the older group (III) than in 
the younger (I and II) groups (P < 0.05). Regression analysis demonstrated a decrease in the 
incidence of normal sperm with increasing age (P < 0.05; r = −0.10). There was a positive cor-
relation between the percentage of spermatozoa with LNV and male age (P < 0.05, r = 0.10).
These results demonstrated a consistent decline in semen quality, as reflected by morphologi-
cal evaluation following IMSI with increased age, and support the routine use of IMSI for ICSI 
as a criterion for semen analysis in older group of patients.
8. Conclusions
The introduction to IMSI enabled to morphologically evaluate the individual motile sperm cell 
prior to its injection into the oocyte. The possibility to correlate each injected spermatozoon 
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to the specific in vitro developing embryo has led to a better understanding of which sperm 
characteristics should be examined. Selecting a good-quality spermatozoon with normal 
morphology by using IMSI might be beneficial to embryonic development and to increased 
implantation and pregnancy rates. Taking into consideration the vast amount of knowledge 
accumulated, it seems that there is no advantage to recommend IMSI as a routine procedure 
for the entire populations referred to IVF-ICSI. In regard to the aforementioned studies and 
the experience accumulated, the authors pointed out that the following populations will have 
higher chances to conceive, while addressed to IMSI are couples with repeated implanta-
tion failures, cases of severe male factor infertility, advanced male age (>41 years old), and 
advanced maternal age (>30 years old). However, the latest should be considered in combina-
tion with deteriorated sperm quality.
It is also suggested to perform an independent observational diagnosis, using high magnifica-
tion for the motile spermatozoa on a processed specimen prior to the time of the ICSI/IMSI 
procedure. This gives the laboratory an idea about the percentage of high-quality spermato-
zoa. In normospermia cases, according to routine sperm analyses, it is recommended to refer 
the couples to IMSI only when IMSI pre-analysis demonstrated less than 7% of high-scored 
(score 4–6) motile spermatozoa (Barak and Ellenbogen, personal communication). Moreover, 
according to the current knowledge no prenatal or postnatal complications in the mothers and 
offspring were observed following the IMSI procedure. The effectiveness of IMSI is still contro-
versial mainly due to variations in inclusion criteria, stimulation protocols, sperm and oocyte 
qualities, and many additional confounding variables frequent in the IVF cycles.
However, there is no doubt that usage of the IMSI technique definitely opened a wider door 
for the hope of couples in their journey to fulfill their wish for a child. Further investigations 
should take place, to improve our knowledge in using this technique.
A. Appendix
General view of spermatozoa during IMSI.
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